Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Opioids Stories

2012-07-20 10:22:57

NEW YORK, July 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that their July 12th RetailInvestorConferences.com presentation is now available for on-demand viewing. LINK: www.retailinvestorconferences.com > red "register/ watch event now" button AcelRx Pharmaceuticals, Inc.'s presentation...

2012-07-16 22:20:36

BARCELONA, July 17, 2012 /PRNewswire/ -- - The sigma-1 receptor (S1R) is an important development target for innovative medications to treat neuropathic pain, for which new medications are much needed. - Developed by ESTEVE, E-52862 is a potent, highly selective NCE with a novel mechanism of action (S1R antagonism) currently being evaluated for the treatment of pain. - In studies conducted to date in...

2012-07-12 06:22:33

CHICAGO, July 12, 2012 /PRNewswire/ -- According to Michael Wong of the Physician-Patient Alliance for Health & Safety, the topic of who is a suitable candidate for outpatient surgery is front and center with productivity pressures being intense at ambulatory surgery centers. However, with surgery often comes the necessity of the use of opioids for pain control. As Mr. Wong explains, "Studies have shown that any patient receiving opioids may be at risk of postoperative respiratory...

2012-07-10 06:26:55

NEW YORK, July 10, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, Chief Executive Officer, Pamela Palmer, Founder and Chief Medical Officer, and Jim Welch, Chief Financial Officer, will co-present at RetailInvestorConferences.com. DATE: July 12, 2012 TIME:...

2012-07-09 14:23:16

STAMFORD, Conn., July 9, 2012 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) is requiring opioid analgesic companies to implement a new, shared Risk Evaluation & Mitigation Strategy (REMS) for all extended-release and long-acting opioid pain medications to ensure that the benefits continue to outweigh the risks of adverse outcomes (addiction, unintentional overdose, and death) resulting from inappropriate prescribing, abuse, and misuse. The principal components of this REMS...

2012-07-09 10:23:53

GLENVIEW, Ill., July 9, 2012 /PRNewswire-USNewswire/ -- The American Academy of Pain Medicine, which represents 2,600 pain physicians and treatment teams, issued the following statement today in response to the FDA's issuance of the Risk Evaluation and Mitigation Strategy (REMS) for opioids: As the premiere medical association of pain physicians, we applaud the FDA's issuance of the Risk Evaluation and Mitigation Strategy (REMS) for opioids. It is a huge leap forward. We are pleased to have...

2012-07-09 02:24:56

RALEIGH, N.C., July 9, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at this year's JMP Securities Healthcare Conference. The presentation is scheduled for Friday, July 13, 2012 at 1:00 p.m. Eastern Time, at The Peninsula Hotel in New York City. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo will focus on BDSI's progress with the clinical...

Pharma Begins OxyContin Trials In Children
2012-07-04 10:32:47

Lawrence LeBlond for redOrbit.com - Your Universe Online Purdue Pharma, the maker of the widely-used, and equally-abused drug, OxyContin, is now looking to gain 6 extra months of patent protection with new clinical trials that could possibly see market of the drug to children. The patent on the potent painkiller is set to expire in 2013 and Purdue, following in the footsteps of other drugmakers that have pursued pediatric-exclusivity, is testing the drug´s potential for use in...

Methadone Linked To Increase In Painkiller Deaths
2012-07-04 06:09:45

Connie K. Ho for redOrbit.com — Your Universe Online The U.S. Center for Disease Control and Prevention (CDC) recently announced that the prescription drug methadone accounted for over 30 percent of prescription painkiller overdose deaths, even though there were only two percent of painkiller prescriptions in the U.S. in 2009. The findings were published in a recent CDC Vital Signs report. Researchers examined national data from 1999 to 2010, with the 2009 data pooled from 13...

2012-07-02 23:00:41

Drug testing is among the most effective ways for physicians to detect and prevent prescription drug diversion and abuse and is an essential tool in the patient treatment process today. (PRWEB) July 01, 2012 The prescription drug abuse problem has skyrocketed in the past decade. According to the Center for Disease Control (CDC), over 20,000 Americans die each year of prescription drug abuse. Opioid pain relievers now account for more overdose deaths than cocaine and heroin combined. The...